Rigel Pharmaceuticals, Inc. (RIGL)
45.16
-0.72
(-1.58%)
USD |
NASDAQ |
Aug 24, 16:00
45.16
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Market Cap : 842.50M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 856.03M |
| August 20, 2026 | 844.09M |
| August 19, 2026 | 875.99M |
| August 18, 2026 | 813.68M |
| August 17, 2026 | 791.86M |
| August 14, 2026 | 794.28M |
| August 13, 2026 | 760.89M |
| August 12, 2026 | 781.04M |
| August 11, 2026 | 783.84M |
| August 10, 2026 | 777.12M |
| August 07, 2026 | 749.33M |
| August 06, 2026 | 731.61M |
| August 05, 2026 | 755.11M |
| August 04, 2026 | 721.91M |
| August 03, 2026 | 698.22M |
| July 31, 2026 | 680.31M |
| July 30, 2026 | 703.41M |
| July 29, 2026 | 722.08M |
| July 28, 2026 | 711.54M |
| July 27, 2026 | 691.03M |
| July 24, 2026 | 679.01M |
| July 23, 2026 | 680.49M |
| July 22, 2026 | 698.60M |
| July 21, 2026 | 726.51M |
| July 20, 2026 | 733.17M |
| Date | Value |
|---|---|
| July 17, 2026 | 749.24M |
| July 16, 2026 | 770.13M |
| July 15, 2026 | 761.07M |
| July 14, 2026 | 760.89M |
| July 13, 2026 | 763.29M |
| July 10, 2026 | 786.39M |
| July 09, 2026 | 808.75M |
| July 08, 2026 | 793.42M |
| July 07, 2026 | 786.58M |
| July 06, 2026 | 743.98M |
| July 02, 2026 | 715.61M |
| July 01, 2026 | 707.66M |
| June 30, 2026 | 723.00M |
| June 29, 2026 | 721.52M |
| June 26, 2026 | 715.05M |
| June 25, 2026 | 683.63M |
| June 24, 2026 | 675.50M |
| June 23, 2026 | 658.13M |
| June 22, 2026 | 660.35M |
| June 18, 2026 | 608.23M |
| June 17, 2026 | 616.73M |
| June 16, 2026 | 599.91M |
| June 15, 2026 | 617.66M |
| June 12, 2026 | 607.12M |
| June 11, 2026 | 592.89M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ironwood Pharmaceuticals, Inc. | 681.61M |
| Cytokinetics, Inc. | 10.70B |
| Perspective Therapeutics, Inc. | 362.79M |
| Capricor Therapeutics, Inc. | 395.72M |
| ACADIA Pharmaceuticals, Inc. | 5.100B |
Market Cap Related Metrics
| PE Ratio | 2.767 |
| PS Ratio | 3.190 |
| PEG Ratio | 0.0138 |
| Price to Book Value | 1.980 |
| Price to Free Cash Flow | 97.66 |
| Price | 45.16 |
| Earnings Yield | 36.14% |
| PEGY Ratio | 0.0138 |
| Operating PE Ratio | 10.14 |
| Normalized PE Ratio | 2.766 |